Christian Behrenbruch Insider Profile

11 Followers
Christian Behrenbruch, Director at Amplia Therapeutics Ltd., holds 23.23M shares in Telix Pharmaceuticals Ltd. (Ticker: TLPPF), holds 2.74M shares in Amplia Therapeutics Ltd. (Ticker: INNMF).
tipranks
Christian  Behrenbruch

Christian Behrenbruch
Amplia Therapeutics Ltd. (INNMF)
Director

Ranked #27,598 out of 99,218 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+66.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$350M
99.95%
0.05%
A breakdown of Christian Behrenbruch's holdings

Insider Roles

Telix Pharmaceuticals Ltd.
(TLPPF)
Managing Director & Chief Executive Officer
Amplia Therapeutics Ltd.
(INNMF)
Director
Roles that Christian Behrenbruch holds in companies

Most Profitable Insider Trade

Stock:
Amplia Therapeutics Ltd.
(INNMF)
Rating:Informative Buy
Date:Sep 17, 2019 - Sep 17, 2020
Return:+133.30%
The most profitable trade made by Christian Behrenbruch

Christian Behrenbruch's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Amplia Therapeutics Ltd.
Sep 17, 2019
Director
Informative Buy
25.00K
$172.75K
Telix Pharmaceuticals Ltd.
Jan 22, 2024
Managing Director & Chief Executive Officer
Uninformative Sell
$349.59M
List of latest transactions for each holding click on a transaction to see Christian Behrenbruch's performance on stock

Christian Behrenbruch insider profile FAQ

What is the percentage of profitable transactions made by Christian Behrenbruch?
The percentage of profitable transactions made by Christian Behrenbruch is 50%.
    What is the average return per transaction made by Christian Behrenbruch?
    The average return per transaction made by Christian Behrenbruch is 66.10%.
      What stocks does Christian Behrenbruch hold?
      Christian Behrenbruch holds: INNMF, TLPPF stocks.
        What was Christian Behrenbruch’s latest transaction?
        Christian Behrenbruch latest transaction was an Uninformative Sell of ―.
          What was Christian Behrenbruch's most profitable transaction?
          Christian Behrenbruch’s most profitable transaction was an Informative Buy of INNMF stock on September 17, 2019. The return on the trade was 133.30%.
            What is Christian Behrenbruch's role in Amplia Therapeutics Ltd.?
            Christian Behrenbruch's role in Amplia Therapeutics Ltd. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.